Results 21 to 30 of about 12,476,006 (287)

The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. [PDF]

open access: yes, 2009
BACKGROUND: Extrapulmonary small cell carcinoma (EPSCC) is a rare cancer and few studies describe its epidemiology. Our objectives were to compare the incidence and survival of EPSCC in South East England with small cell carcinoma of the lung (SCLC), to ...
Jack, Ruth H   +18 more
core   +2 more sources

Spindle Cell Metaplastic Breast Carcinoma with Leiomyoid Differentiation: A Case Report [PDF]

open access: yes, 2011
Background: Metaplastic carcinoma of the breast is a rare but distinct entity within the group of undifferentiated invasive carcinomas. This entity accounts for less than 0.5% of all breast cancers and contains elements of epithelial (ductal ...
Jauch, Karl-Walter   +11 more
core   +1 more source

Surgical management for upper urinary tract transitional cell carcinoma [PDF]

open access: yes, 2011
Background Upper tract transitional cell carcinomas (TCC) are uncommon and aggressive tumours. There are a number of surgical approaches to manage this condition including open radical nephroureterectomy and laparoscopic procedures.
El-Mokadem, Ismail   +11 more
core   +1 more source

The role of GLI2 in human basal cell carcinoma tumourigenesis [PDF]

open access: yes, 2010
PhDAbnormal Sonic Hedgehog (SHH) signalling leads to increased transcriptional activation of its downstream effector, GLI2, which is implicated in the pathogenesis of a variety of human tumours, including human basal cell carcinoma (BCC).
Pantazi, Eleni
core   +4 more sources

Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

open access: yesFrontiers in Oncology, 2018
Purpose: Atezolizumab is a programmed death ligand 1 (PDL-1) blocking antibody that was approved for metastatic non-small cell lung cancer (NSCLC) in patients with disease progression.
Rachel Ryu, Kristina E. Ward
doaj   +1 more source

Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery [PDF]

open access: yes, 2014
Background:Wider clinical applications of 9p status in clear cell renal cell carcinoma (ccRCC) are limited owing to the lack of validation and consensus for interphase fluorescent in situ hybridisation (I-FISH) scoring technique.
Fleming, S.   +15 more
core   +1 more source

Differences in Characteristics and Outcomes Between Large-Cell Neuroendocrine Carcinoma of the Ovary and High-Grade Serous Ovarian Cancer: A Retrospective Observational Cohort Study

open access: yesFrontiers in Oncology, 2022
BackgroundOwing to its extremely low incidence and the paucity of relevant reports, there is currently no recognized first-line treatment strategy for ovarian large-cell neuroendocrine carcinoma, and there are no statistics related to prognosis derived ...
Li Pang, Zhiqiang Guo
doaj   +1 more source

Surgical management of oral squamous cell carcinoma infiltrating mandible [PDF]

open access: yes, 2008
Progression of recent trends in mandible-preserving operations for the management of oral squamous cell carcinomas that infiltrate the mandible is rapid and accompanying studies give invaluable information concerning behavioral understanding of oral ...
Kim, Hyung Jun
core   +1 more source

The role of FOXM1 in oral squamous cell carcinoma [PDF]

open access: yes, 2010
PhDFOXM1 transcription factor regulates the expression of a multitude of genes, which are important for cell proliferation, mitosis, and differentiation.
Gemenetzidis, Emilios
core   +4 more sources

New models of large-cell neuroendocrine carcinoma and small-cell lung carcinoma

open access: yesMolecular & Cellular Oncology, 2020
High-grade neuroendocrine lung carcinomas (LCNEC, SCLC) are recalcitrant cancers for which no optimal management has been achieved. We have recently described two models of LCNEC and SCLC developed upon inactivation of 4 tumor suppressors genes (Rb1 (RB ...
Mirentxu Santos
doaj   +1 more source

Home - About - Disclaimer - Privacy